Originally posted here
Two University of Oxford alumni-led startups, iLoF and Pipra, were recently funded by the European Institute of Technology for Health (EIT Health).
PIPRA (short for Pre-Interventional Preventive Risk Assessment), is addressing this urgent orphan need by developing an AI-powered software that assesses your risk of developing postoperative delirium. Clinicians fill out a few questions about the patient to get the result. Patients found to be at risk can benefit from proven risk reduction options such as the Hospital Elder Life Program, or might even decide to cancel their operation altogether.
iLoF has created a portable system that serves as a digital library for fingerprints of various neurodegenerative diseases and allows rapid and non-invasive patient stratification for neurodegenerative diseases such as Alzheimer’s. Their objective is to change the paradigm using methods such as artificial intelligence and photonics to tackle the current issues with clinical trials and accelerate the development of new and personalised treatments for Alzheimer’s disease.